Symic Bio is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease.
While it is clear that cells play an important role in tissue inflammation and regeneration, it is also known that the extracellular matrix (ECM) plays an equally critical role in maintaining healthy tissue.
The ECM is the non-cellular component of the body’s tissues, and proteoglycans are important structural and functional macromolecules native to the ECM that are known to protect against tissue degradation and promote healing during illness or injury.
Therapeutic Area & Clinical Targets . Rheumatology/Immunology Osteoarthritis, Disease Modifying